Aveo Oncology - Ownership and Business Overview

Life ScienceCompany

Aveo Oncology Ownership

Who owns Aveo Oncology?

Aveo Oncology is owned by LG Chem. It was acquired on January 19, 2023.

Aveo Oncology Business Overview

Where is Aveo Oncology headquartered?

Aveo Oncology is headquartered in Boston, Massachusetts.

What is Aveo Oncology’s revenue?

Aveo Oncology disclosed revenue of 42M USD for 2021 and 6M USD for 2020.

What sector is Aveo Oncology in?

Aveo Oncology is a life science company.

When was Aveo Oncology founded?

Aveo Oncology was founded in 2001.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 204 acquisitions of life science companies in 2023, including 26 acquisitions by private equity firms, and 178 by strategics.

Aveo Oncology

Aveo Pharmaceuticals, Inc.

30 Winter Street,
Boston, Massachusetts 02108
United States,
(857) 400-0101
www.aveopharma.com

Aveo Oncology is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics. Aveo Oncology's product candidates are targeted against important mechanisms known or believed to be involved in cancer. Aveo Oncology was founded in 2001 and is based in Boston, Massachusetts.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.